Page last updated: 2024-10-25

ciprofloxacin and Cardiotoxicity

ciprofloxacin has been researched along with Cardiotoxicity in 1 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.

Research Excerpts

ExcerptRelevanceReference
"This study was designed to investigate the impacts of Doxo alone and in combination with Cipro on the hepatic and cardiac CYP1A2, CYP2J3, and CYP3A1 mRNA levels."5.91Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function. ( Basci, AB; Eyileten, C; Karatas, OF; Postula, M; Shahzadi, A; Suzer, O; Tanoglu, EG; Yazici, Z, 2023)
"This study was designed to investigate the impacts of Doxo alone and in combination with Cipro on the hepatic and cardiac CYP1A2, CYP2J3, and CYP3A1 mRNA levels."1.91Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function. ( Basci, AB; Eyileten, C; Karatas, OF; Postula, M; Shahzadi, A; Suzer, O; Tanoglu, EG; Yazici, Z, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Shahzadi, A3
Eyileten, C3
Postula, M3
Tanoglu, EG3
Karatas, OF3
Basci, AB3
Suzer, O3
Yazici, Z3

Other Studies

1 other study available for ciprofloxacin and Cardiotoxicity

ArticleYear
Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function.
    Naunyn-Schmiedeberg's archives of pharmacology, 2023, Volume: 396, Issue:7

    Topics: Animals; Cardiotoxicity; Ciprofloxacin; Cytochrome P-450 CYP1A2; Doxorubicin; Heart; Liver; Rats

2023
Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function.
    Naunyn-Schmiedeberg's archives of pharmacology, 2023, Volume: 396, Issue:7

    Topics: Animals; Cardiotoxicity; Ciprofloxacin; Cytochrome P-450 CYP1A2; Doxorubicin; Heart; Liver; Rats

2023
Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function.
    Naunyn-Schmiedeberg's archives of pharmacology, 2023, Volume: 396, Issue:7

    Topics: Animals; Cardiotoxicity; Ciprofloxacin; Cytochrome P-450 CYP1A2; Doxorubicin; Heart; Liver; Rats

2023
Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function.
    Naunyn-Schmiedeberg's archives of pharmacology, 2023, Volume: 396, Issue:7

    Topics: Animals; Cardiotoxicity; Ciprofloxacin; Cytochrome P-450 CYP1A2; Doxorubicin; Heart; Liver; Rats

2023
Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function.
    Naunyn-Schmiedeberg's archives of pharmacology, 2023, Volume: 396, Issue:7

    Topics: Animals; Cardiotoxicity; Ciprofloxacin; Cytochrome P-450 CYP1A2; Doxorubicin; Heart; Liver; Rats

2023
Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function.
    Naunyn-Schmiedeberg's archives of pharmacology, 2023, Volume: 396, Issue:7

    Topics: Animals; Cardiotoxicity; Ciprofloxacin; Cytochrome P-450 CYP1A2; Doxorubicin; Heart; Liver; Rats

2023
Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function.
    Naunyn-Schmiedeberg's archives of pharmacology, 2023, Volume: 396, Issue:7

    Topics: Animals; Cardiotoxicity; Ciprofloxacin; Cytochrome P-450 CYP1A2; Doxorubicin; Heart; Liver; Rats

2023
Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function.
    Naunyn-Schmiedeberg's archives of pharmacology, 2023, Volume: 396, Issue:7

    Topics: Animals; Cardiotoxicity; Ciprofloxacin; Cytochrome P-450 CYP1A2; Doxorubicin; Heart; Liver; Rats

2023
Investigation of doxorubicin combined with ciprofloxacin-induced cardiotoxicity: from molecular mechanism to fundamental heart function.
    Naunyn-Schmiedeberg's archives of pharmacology, 2023, Volume: 396, Issue:7

    Topics: Animals; Cardiotoxicity; Ciprofloxacin; Cytochrome P-450 CYP1A2; Doxorubicin; Heart; Liver; Rats

2023